TxCell SA
Industry
- Pharmaceuticals
- Biotechnology
- Gene Therapy, Cell Therapy
Latest on TxCell SA
Established only last year and incorporated in France and Spain with an initial seed from Paris-based VC firm AdBio Partners, Kiji Therapeutics is grounded in science from the Spanish public research
T-cell therapies are all the rage in immuno-oncology drug development but have not gained quite the same momentum in autoimmune and inflammatory diseases – unless recent financings are a sign of thing
AstraZeneca: 2019 Net Price Decreases AstraZeneca PLC 's 2019 net prices on average across the portfolio will decrease versus 2018, Senior VP-Market Access Rick Suarez said in an interview at J.P. Mo
Despite stock values ending the year down as investor sentiment turned negative in the last few months of 2018, biopharmaceutical investors and executives at the J.P. Morgan Healthcare Conference Jan.